tweenvest

Ingenia Therapeutics Inc. (KOSDAQ: A950260)

Health Care · Biotechnology · US

₩20,350.00

+1.24% today · +13.1% 1Y

Public summary
A free snapshot of Ingenia Therapeutics Inc., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Ingenia Therapeutics Inc. (KOSDAQ: A950260) operates in the Biotechnology industry within the Health Care sector. The company is valued at $752.71M.

Over the last twelve months the share price has gained 13.1%, trading between 9.90K and 29.95K.

Tweenvest scores Ingenia Therapeutics Inc. across four factors: quality 56/100, value 67/100. Its strongest factor is value.

A950260 price history

Aug 21, 2026 · 15,770.00Weekly closes 15,450.00 – 28,850.00Nov 16, 2026 · 20,350.00

Key figures

Market cap
$752.71M
Revenue (TTM)
$4.79M
P/E
-97.12
EPS
-163.00
Dividend yield
—
Beta (5Y)
—
52-week high
₩29,950.00
52-week low
₩9,900.00
Avg volume (3M)
—
Shares outstanding
49.44M
Employees
—
Next earnings
—
CompanyMarket capPriceDay
Monte Rosa Therapeutics, Inc.NasdaqGS: GLUE$775.03M$9.070.00%
Kolon TissueGene, Inc.KOSDAQ: A950160$772.30M₩12,150.00-3.19%
Obsidian Therapeutics, Inc.NasdaqCM: OBX$754.25M$12.21+1.16%
Inventiva S.A.ENXTPA: IVA$753.92M€2.91+0.69%
Nanjing Leads Biolabs Co., Ltd.SEHK: 9887$748.03MHK$30.08-1.96%
Beijing SL Pharmaceutical Co., Ltd.SZSE: 002038$745.83MCN¥4.84-2.22%
Aura Biosciences, Inc.NasdaqGM: AURA$743.09M$7.14-0.14%
Sagimet Biosciences Inc.NasdaqGM: SGMT$721.53M$10.11+2.54%

Browse every Biotechnology company →